Safety of Low-Molecular-Weight Heparin Compared to Unfractionated Heparin in Hemodialysis: A Systematic Review and Meta-Analysis

BMC Nephrology - United Kingdom
doi 10.1186/s12882-017-0596-4
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Unfractionated Heparin in the Pathogenesis of Abnormal Lipid Metabolism in Hemodialysis Patients. Comparison With Low-Molecular-Weight Heparin.

Nihon Toseki Igakkai Zasshi
1994English

Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin During Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis

BMJ
2012English

Low Molecular Weight Heparin or Unfractionated Heparin in the Treatment of Patients With Uncomplicated Deep Vein Thrombosis

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2000English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Low Molecular Weight Heparin Versus Unfractionated Heparin for Thromboprophylaxis in Patients With Acute Atrial Fibrillation: A Randomized Control Trial

Acute Cardiac Care
Nuclear MedicineRadiologyEmergency MedicineCardiologyCardiovascular MedicineImaging
2011English

Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfractionated Heparin for Acute Ischemic Stroke (Cochrane Review)

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy